326 - 350 of 6560 Results
Title
Year
-
OPENTitle: Cerebral dopamine neurotrophic factor and its functional fragments induce calcium signal through sigma-1 receptor and protect neurons against glutamate-induced excitotoxicityJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 195Issue #:Start Page: 119034End Page: 119034Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.biopha.2026.119034Best OA location URL: https://doi.org/10.1016/j.biopha.2026.119034Citation Count: 0
-
OPENTitle: Elucidating the Role of Site-Specific Nitration of α-Synuclein in the Pathogenesis of Parkinson’s Disease via Protein Semisynthesis and MutagenesisJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 137Issue #: 15Start Page: 5041End Page: 5052Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/ja5131726Best OA location URL: http://infoscience.epfl.ch/record/208178Citation Count: 166
-
OPENTitle: Human progenitor cells isolated from the developing cortex undergo decreased neurogenesis and eventual senescence following expansion in vitroJournal Name: Experimental Cell ResearchPublisher: Elsevier BVVol: 312Issue #: 11Start Page: 2107End Page: 2120Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.yexcr.2006.03.012Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0014482706000966Citation Count: 136
- Oral Transport, Penetration, and Aspiration in PD: Insights from a RCT on STN + SNr Stimulation2024OPENTitle: Oral Transport, Penetration, and Aspiration in PD: Insights from a RCT on STN + SNr StimulationJournal Name: DysphagiaPublisher: Springer Science and Business Media LLCVol: 40Issue #: 4Start Page: 811End Page: 822Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00455-024-10779-yBest OA location URL: https://doi.org/10.15496/publikation-122075Citation Count: 2
-
OPENTitle: Unraveling the Biologic Basis for Domain-Specific Cognitive DeclineJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 25Issue #: 7Start Page: 741End Page: 743Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2017.04.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5870749Citation Count: 1
-
OPENTitle: Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect ofl‐DOPAtreatment and changes in levodopa‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 141Issue #: 4Start Page: 614End Page: 625Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.13997Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13997Citation Count: 44
-
OPENTitle: Plasma Glucosylsphingosine in GBA1 E365K , N409S, and L483P Heterozygous Mutation CarriersJournal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 5Start Page: 1304End Page: 1309Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70205Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70205Citation Count: 0
- The challenges of experimental pharmacology in identifying novel treatments for Parkinson's disease2026OPENTitle: The challenges of experimental pharmacology in identifying novel treatments for Parkinson's diseaseJournal Name: Current Opinion in NeurobiologyPublisher: Elsevier BVVol: 97Issue #:Start Page: 103164End Page: 103164Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.conb.2025.103164Best OA location URL: https://doi.org/10.1016/j.conb.2025.103164Citation Count: 2
-
OPENTitle: Pure Autonomic Failure Versus Prodromal Dysautonomia in Parkinson's Disease: Insights from the BedsideJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 1Start Page: 141End Page: 144Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12360Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12360Citation Count: 13
-
OPENTitle: Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteinsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 79Issue #:Start Page: 1End Page: 13Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.032Best OA location URL: https://doaj.org/article/93e67a90244e4782905f49cf680c102fCitation Count: 47
-
OPENTitle: Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and InternalizationJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 291Issue #: 9Start Page: 4374End Page: 4385Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m115.705095Best OA location URL: http://www.jbc.org/article/S0021925820435859/pdfCitation Count: 165
-
OPENTitle: Discovery and characterization of N-(1,3-dialkyl-1H-indazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine scaffold as mGlu4 positive allosteric modulators that mitigate CYP1A2 induction liabilityJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 28Issue #: 15Start Page: 2641End Page: 2646Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2018.06.034Best OA location URL: https://doi.org/10.7270/q2dr2z5hCitation Count: 14
-
OPENTitle: Epigenomic profile of GBA1 in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 140Issue #:Start Page: 108066End Page: 108066Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108066Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC12825421/Citation Count: 1
-
OPENTitle: Olfaction in Neuropathologically Defined Progressive Supranuclear PalsyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1700End Page: 1704Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28568Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9972484Citation Count: 19
-
OPENTitle: Small intestinal bacterial overgrowth in Parkinson's disease: Tribulations of a trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 54Issue #:Start Page: 110End Page: 112Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.04.003Best OA location URL: https://zenodo.org/record/3832125Citation Count: 36
-
OPENTitle: Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale‐2 in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 2Start Page: 285End Page: 291Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27575Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6532623Citation Count: 19
- Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate2020OPENTitle: Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidateJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 138Issue #:Start Page: 104789End Page: 104789Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104789Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104789Citation Count: 34
-
OPENTitle: Evolving Applications, Technological Challenges and Future Opportunities in Neuromodulation: Proceedings of the Fifth Annual Deep Brain Stimulation Think TankJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page: 734End Page: 734Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2017.00734Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2017.00734/pdfCitation Count: 77
-
OPENTitle: Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activityJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 9Issue #: 11Start Page: 1295End Page: 1305Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.025684Best OA location URL: http://dmm.biologists.org/content/dmm/9/11/1295.full.pdfCitation Count: 69
- Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain2014OPENTitle: Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrainJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 2Start Page: 1110End Page: 1120Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.047Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.07.047Citation Count: 22
-
OPENTitle: Automated Quality Control for Sensor Based Symptom Measurement Performed Outside the LabJournal Name: SensorsPublisher: MDPI AGVol: 18Issue #: 4Start Page: 1215End Page: 1215Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s18041215Best OA location URL: https://www.mdpi.com/1424-8220/18/4/1215/pdf?version=1525348690Citation Count: 26
-
OPENTitle: Generation of two isogenic control iPSC lines (LCSBi001-A-2 and LCSBi001-A-3) from a Parkinson’s disease patient line (LCSBi001-A) carrying the pathogenic VPS35 p.D620N mutationJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 92Issue #:Start Page: 103944End Page: 103944Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.scr.2026.103944Best OA location URL: https://doi.org/10.1016/j.scr.2026.103944Citation Count: 0
-
OPENTitle: Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the BrainJournal Name: Molecular Therapy - Methods & Clinical DevelopmentPublisher: Elsevier BVVol: 11Issue #:Start Page: 29End Page: 39Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtm.2018.08.008Best OA location URL: http://www.cell.com/article/S2329050118300895/pdfCitation Count: 20
-
OPENTitle: Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 2Issue #: 10Start Page: 949End Page: 959Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.246Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.246Citation Count: 202
-
OPENTitle: A Modified Reading the Mind in the Eyes Test Predicts Behavioral Variant Frontotemporal Dementia Better Than Executive Function TestsJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page: 11End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2018.00011Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2018.00011/pdfCitation Count: 43